Drug-Induced Liver Injury with Novel Fat Burner AlbutarexV2 in an Active Duty Sailor

Drug-induced liver injury ranges from asymptomatic to liver failure with supplements becoming an increasingly recognized cause. This case highlights the unique supplement, AlbutarexV2, and the severe cholestatic liver injury it induced with resolution occurring in six months. With steadily increasing obesity rates and supplement use, weight-loss supplements are gaining popularity with various claims of increasing energy expenditure or metabolic rate. Recognition of adverse effects from these therapies is critical to aid in identification and cessation of the agent and helping ban harmful supplements. This case demonstrates the danger of "fat-burners" and delineates the protracted and prolonged liver injury of AlbutarexV2.